Mepolizumab for the treatment of refractory chronic cough in patients with eosinophilic airways disease (MUCOSA): a randomized, double-blind, parallel-group, placebo-controlled trial

Authors

John A. Smith (ORCID: https://orcid.org/0000-0001-8837-4928)
Jennifer Wattie
Catie Obminski
Roma Sehmi (ORCID: https://orcid.org/0000-0003-0968-6304)
Gail M. Gauvreau (ORCID: https://orcid.org/0000-0002-6187-2385)
Sue Beaudin
Paul M. O’Byrne (ORCID: https://orcid.org/0000-0003-0979-281X)
Karen Howie
Elena Kum (ORCID: https://orcid.org/0000-0002-6548-2632)
Lesley Wiltshire
Imran Satia (ORCID: https://orcid.org/0000-0003-4206-6000)
Kimberley Holt (ORCID: https://orcid.org/0000-0003-0413-8085)
Wafa Hassan (ORCID: https://orcid.org/0000-0002-1461-4367)
Danica Brister (ORCID: https://orcid.org/0009-0001-9497-2104)
Nermin Diab (ORCID: https://orcid.org/0000-0002-7045-6092)
Mustafaa Wahab
Kieran J. Killian

Institutions

University of Calgary (CA)
McGill University Health Centre (CA)
University of Manchester (GB)
McGill University (CA)
St. Joseph’s Healthcare Hamilton (CA)
McMaster University (CA)

Publication Details

Journal: European Respiratory Journal
Published: 2025-11-06
DOI: https://doi.org/10.1183/13993003.01573-2025
Primary Topic: Asthma and respiratory diseases
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Mepolizumab for the treatment of refractory chronic cough in patients with eosinophilic airways disease (MUCOSA): a randomized, double-blind, parallel-group, placebo-controlled trial

John A. Smith, Jennifer Wattie, Catie Obminski, Roma Sehmi et al.

Nov 6, 2025

European Respiratory Journal

Asthma and respiratory diseases

article

Mepolizumab for the treatment of refractory chronic cough in patients with eosinophilic airways disease (MUCOSA): a randomized, double-blind, parallel-group, placebo-controlled trial

John A. Smith, Jennifer Wattie, Catie Obminski, Roma Sehmi, Gail M. Gauvreau, Sue Beaudin, Paul M. O’Byrne, Karen Howie, Elena Kum, Lesley Wiltshire, Imran Satia, Kimberley Holt, Wafa Hassan, Danica Brister, Nermin Diab, Mustafaa Wahab, Kieran J. Killian

November 6, 2025article en

Abstract

No abstract available for this paper.

European Respiratory Journal

University of Calgary (CA), McGill University Health Centre (CA), University of Manchester (GB), McGill University (CA), St. Joseph’s Healthcare Hamilton (CA), McMaster University (CA)

Openalex Percentile: Top 59%

Asthma and respiratory diseases

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Mepolizumab for the treatment of refractory chronic cough in patients with eosinophilic airways disease (MUCOSA): a randomized, double-blind, parallel-group, placebo-controlled trial — John A. Smith, Jennifer Wattie, et al. · European Respiratory Journal (2025) | TGRS Research Map | TGRS